AbbVie Inc at TD Cowen Healthcare Conference Transcript
So good morning once again, and welcome to TD Cowen's 46th Annual Healthcare Conference. We're absolutely delighted to have AbbVie back with us again this year. And representing the company, we have three members of management Scott Reents, who is Executive Vice President and CFO; Jeff Stewart, who is the Executive Vice President and Chief Commercial Officer; and Roopal Thakkar, who is Executive Vice President, R&D and CSO.
So thank you for making the journey to be with us. Lots to talk about on the outlook for the company, the commercialized products today, as well as what's going on in R&D. And we'd probably like to start there because it is quite likely the case that AbbVie simply doesn't get full credit for what has gone on in the labs and what's going on today, and the growth potential that that could drive.
So we do want to spend some time on that. And why don't we start out there? But this kind of gets to clinical trial conduct. So this is more of a curiosity than anything in mind, but we -- there's a number of big immunology companies in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
